Almut Winterstein, Ph.D., joined the From Florida podcast with Nicci Brown to discuss medical marijuana research.

The study published in the American Journal of Obstetrics and Gynecology highlights the need for women and their providers to carefully examine medications taken during pregnancy.

The U.S. Food and Drug Administration in 2016 took action to reduce the overuse of fluoroquinolones, a type of antibiotic associated with serious side effects. That step helped cut the use of these antibiotics for uncomplicated urinary tract infections, or UTIs, by more than half, according to a University…

The findings are published in July’s issue of Clinical Pharmacology & Therapeutics, the flagship journal of the American Society of Clinical Pharmacology & Therapeutics.

University of Florida researchers determined an FDA-approved program deters pregnant women from starting a potentially harmful immunosuppressive drug. But for women taking the drug, the program was not effective at reducing conception.

Winterstein is the first faculty member from the UF College of Pharmacy to lead the International Society for Pharmacoepidemiology.

The State University System of Florida Board of Governors has selected the University of Florida to lead a statewide consortium studying health outcomes related to medical marijuana. UF will lead the Consortium for Medical Marijuana Clinical Outcomes Research, which will be composed of public and private universities engaged in research…

A new study by University of Florida researchers questions the accuracy of the criteria used by the Centers for Medicare and Medicaid Services to identify patients at risk of opioid abuse and overdose.

A pair of Orlando pharmacy students also placed in the top 10 of the Clinical Skills Challenge at ASHP Midyear.

As president-elect, Winterstein will serve on the executive board and chair the strategic planning committee. She joined ISPE in 2000 and has held numerous leadership roles during the past two decades.